Efficacy of ferric carboxymaltose in iron deficiency anemia patients scheduled for pancreaticoduodenectomy

Perioperative transfusion is reported to be an independent risk factor not only for postoperative complications but also for early recurrence of periampullary carcinoma after pancreaticoduodenectomy (PD). The purpose of this study was to evaluate the safety and efficacy of ferric carboxymaltose (FCM...

Full description

Saved in:
Bibliographic Details
Published in:Annals of surgical treatment and research 2023-08, Vol.105 (2), p.82-90
Main Authors: Park, Jangho, Park, Sang-Jae, Han, Sung-Sik, Park, Hyeong Min, Yu, Jihye, Park, Boram, Kim, Young-Woo, Kim, Sun-Whe
Format: Article
Language:English
Subjects:
Original
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Perioperative transfusion is reported to be an independent risk factor not only for postoperative complications but also for early recurrence of periampullary carcinoma after pancreaticoduodenectomy (PD). The purpose of this study was to evaluate the safety and efficacy of ferric carboxymaltose (FCM) in reducing the need for perioperative transfusion in iron deficiency anemia patients scheduled for PD. Twenty-two male patients (hemoglobin [Hb] 7 to
ISSN:2288-6575
2288-6796
DOI:10.4174/astr.2023.105.2.82